METTL3 Enhances Pancreatic Ductal Adenocarcinoma Progression and Gemcitabine Resistance through Modifying DDX23 mRNA N6 Adenosine Methylation

0
88
N6-methyladenosine methyltransferase METTL3 was upregulated in PDAC tissues with gemcitabine resistance, and its knockdown sensitized pancreatic cancer cells to chemotherapy.
[Cell Death & Disease]
Full Article